These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 37474162)
1. Comparison of antivascular endothelial growth factor treatment for myopia choroidal neovascularisation: a systematic review and meta-analysis of randomised controlled trials. Dong L; Li G; Song Z; Cheng X; Bai J; Zhang C BMJ Open; 2023 Jul; 13(7):e067921. PubMed ID: 37474162 [TBL] [Abstract][Full Text] [Related]
2. Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia. Zhu Y; Zhang T; Xu G; Peng L Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011160. PubMed ID: 27977064 [TBL] [Abstract][Full Text] [Related]
5. Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre. Rishi P; Rishi E; Bhende M; Agarwal V; Vyas CH; Valiveti M; Bhende P; Rao C; Susvar P; Sen P; Raman R; Khetan V; Murali V; Ratra D; Sharma T Br J Ophthalmol; 2016 Oct; 100(10):1337-40. PubMed ID: 26792945 [TBL] [Abstract][Full Text] [Related]
6. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415 [TBL] [Abstract][Full Text] [Related]